FDA's Mansfield heads to Grail

FDA Deputy Director for Personalized Medicine Elizabeth Mansfield is leaving the agency to join cancer screening company Grail Inc. (Menlo Park, Calif.). Grail spokesperson Betsey Rapp told BioCentury that Mansfield will become the company's head of regulatory strategy.

The agency said Mansfield will leave on Feb. 17. She joined FDA in 2006...